GLP-1s: A Head-to-Head Comparison Lets put the speedboat and the cruise ship side-by-side
Many experts suggest that a "dual-action" approach is most effective
The concern about hair loss while using semaglutide has been raised by some patients, though it is not listed as one of the most common side effects
Clinical trial data from early 2026 indicates that postmenopausal women can lose approximately 23% of their body weight on tirzepatide, whereas semaglutide typically results in around 15%
If I had lost almost no weight, just to have my brain working the way its working, I would stay on this medication forever. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing
Whole-person care: Position any peptide within a comprehensive plan (rehab/loading, sleep, nutrition, inflammation management) rather than a stand-alone solution